MA24571A1 - Compositions comprenant un sensibilisant a l'insuline et un secretagogue d'insuline pour une methode de traitement - Google Patents
Compositions comprenant un sensibilisant a l'insuline et un secretagogue d'insuline pour une methode de traitementInfo
- Publication number
- MA24571A1 MA24571A1 MA25120A MA25120A MA24571A1 MA 24571 A1 MA24571 A1 MA 24571A1 MA 25120 A MA25120 A MA 25120A MA 25120 A MA25120 A MA 25120A MA 24571 A1 MA24571 A1 MA 24571A1
- Authority
- MA
- Morocco
- Prior art keywords
- insulin
- compositions
- treatment method
- secretagogue
- sensitizer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9712854.0A GB9712854D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
GBGB9806710.1A GB9806710D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (1)
Publication Number | Publication Date |
---|---|
MA24571A1 true MA24571A1 (fr) | 1998-12-31 |
Family
ID=26311744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25120A MA24571A1 (fr) | 1997-06-18 | 1998-06-17 | Compositions comprenant un sensibilisant a l'insuline et un secretagogue d'insuline pour une methode de traitement |
Country Status (34)
Country | Link |
---|---|
EP (3) | EP1671637A3 (fr) |
JP (1) | JP2001523270A (fr) |
KR (3) | KR20070011651A (fr) |
CN (1) | CN1168451C (fr) |
AP (1) | AP1600A (fr) |
AR (2) | AR008025A1 (fr) |
AT (1) | ATE353654T1 (fr) |
AU (1) | AU8539298A (fr) |
BG (2) | BG64817B1 (fr) |
BR (1) | BR9810142A (fr) |
CA (1) | CA2294385C (fr) |
CO (1) | CO4940457A1 (fr) |
CZ (1) | CZ299310B6 (fr) |
DE (1) | DE69837089T2 (fr) |
DZ (1) | DZ2522A1 (fr) |
EA (1) | EA003025B1 (fr) |
ES (1) | ES2283064T3 (fr) |
HK (1) | HK1028200A1 (fr) |
ID (1) | ID24065A (fr) |
IL (1) | IL133137A (fr) |
IN (1) | IN189319B (fr) |
MA (1) | MA24571A1 (fr) |
MY (1) | MY125855A (fr) |
NO (3) | NO326263B1 (fr) |
NZ (1) | NZ501163A (fr) |
OA (1) | OA11510A (fr) |
PE (1) | PE108199A1 (fr) |
PL (2) | PL337510A1 (fr) |
SK (1) | SK286028B6 (fr) |
TR (1) | TR199903096T2 (fr) |
TW (1) | TW542717B (fr) |
UA (1) | UA67743C2 (fr) |
UY (1) | UY25048A1 (fr) |
WO (1) | WO1998057649A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
EP1173434B1 (fr) | 1999-04-23 | 2003-08-20 | SmithKline Beecham plc | Derive du thiazolindione et son utilisation comme antidiabetique |
WO2001032184A2 (fr) * | 1999-11-01 | 2001-05-10 | Wisconsin Alumni Research Foundation | Gene de transport de cholesterol |
US7964216B2 (en) | 2001-01-12 | 2011-06-21 | Sun Pharma Advanced Research Company Limited | Spaced drug delivery system |
KR100698595B1 (ko) * | 2003-09-29 | 2007-03-21 | 보령제약 주식회사 | 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물 |
US7700128B2 (en) * | 2003-10-31 | 2010-04-20 | Takeda Pharmaceutical Company Limited | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
WO2007072992A2 (fr) | 2005-12-22 | 2007-06-28 | Takeda Pharmaceutical Company Limited | Preparation solide |
CN104158867B (zh) * | 2014-08-06 | 2017-05-17 | 电子科技大学 | 一种基于wave协议的信息多跳转发方法 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
JPS5697277A (en) | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
JPS6051189A (ja) | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
US4582839A (en) | 1984-03-21 | 1986-04-15 | Takeda Chemical Industries, Ltd. | 2,4-thiazolidinediones |
CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物,其制备方法和用途 |
DK173350B1 (da) | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
JPH06779B2 (ja) | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
US4812570A (en) | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
EP0842925A1 (fr) | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Thiazolidinédiones substituées |
US4791125A (en) | 1987-12-02 | 1988-12-13 | Pfizer Inc. | Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents |
WO1989008650A1 (fr) | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Agents hypoglycemiques de thiazolidinedione |
MX15171A (es) | 1988-03-08 | 1993-05-01 | Pfizer | Derivados de tiazolidinodiona hipoglicemicos |
WO1991007107A1 (fr) | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Agents d'oxazolidinedione hypoglycemiques |
US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
KR930701436A (ko) | 1990-07-03 | 1993-06-11 | 오노다 마사아이 | 비스헤테로환 화합물 |
HUT70153A (en) | 1990-08-23 | 1995-09-28 | Pfizer | Hypoglycemic hydroxyurea derivatives |
JPH04210683A (ja) | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
HUT68370A (en) | 1991-04-11 | 1995-06-28 | Takeda Chemical Industries Ltd | Thiazolidine derivatives, pharmaceutical compositions containing them and process for their production |
US5183823A (en) | 1991-04-11 | 1993-02-02 | Takeda Chemical Industries, Ltd. | Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents |
TW222626B (fr) | 1991-07-22 | 1994-04-21 | Pfizer | |
FR2680512B1 (fr) | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
WO1993003724A1 (fr) * | 1991-08-26 | 1993-03-04 | The Upjohn Company | Composition pharmaceutique contenant de l'acide 3-guanidinopropionique ainsi que du glibenclamide ou glimepiride de pioglitazone |
JPH05271204A (ja) | 1992-03-26 | 1993-10-19 | Japan Tobacco Inc | 新規なトリアジン誘導体 |
US5264451A (en) | 1992-04-07 | 1993-11-23 | American Home Products Corporation | Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones |
JPH07505647A (ja) | 1992-04-10 | 1995-06-22 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 複素環化合物および2型糖尿病の治療におけるそれらの使用 |
WO1993022445A1 (fr) | 1992-05-05 | 1993-11-11 | The Upjohn Company | Procede de production de metabolites de pioglitazone |
NZ253742A (en) | 1992-07-03 | 1997-06-24 | Smithkline Beecham Plc | Heterocyclylaminoalkoxy substituted phenyl derivatives and pharmaceutical compositions |
US5232945A (en) | 1992-07-20 | 1993-08-03 | Pfizer Inc. | 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
US5478852C1 (en) | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
US5859037A (en) * | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
-
1998
- 1998-06-15 TR TR1999/03096T patent/TR199903096T2/xx unknown
- 1998-06-15 EP EP06075523A patent/EP1671637A3/fr not_active Ceased
- 1998-06-15 KR KR1020077000227A patent/KR20070011651A/ko not_active Application Discontinuation
- 1998-06-15 PL PL98337510A patent/PL337510A1/xx not_active Application Discontinuation
- 1998-06-15 AU AU85392/98A patent/AU8539298A/en not_active Abandoned
- 1998-06-15 PL PL377979A patent/PL198018B1/pl not_active IP Right Cessation
- 1998-06-15 ID IDW991628A patent/ID24065A/id unknown
- 1998-06-15 JP JP50375499A patent/JP2001523270A/ja active Pending
- 1998-06-15 AP APAP/P/1999/001717A patent/AP1600A/en active
- 1998-06-15 EP EP10176770A patent/EP2266576A1/fr not_active Withdrawn
- 1998-06-15 DE DE69837089T patent/DE69837089T2/de not_active Expired - Lifetime
- 1998-06-15 AT AT98936363T patent/ATE353654T1/de not_active IP Right Cessation
- 1998-06-15 SK SK1791-99A patent/SK286028B6/sk not_active IP Right Cessation
- 1998-06-15 KR KR1019997011861A patent/KR20010013840A/ko not_active Application Discontinuation
- 1998-06-15 IL IL13313798A patent/IL133137A/en not_active IP Right Cessation
- 1998-06-15 CA CA002294385A patent/CA2294385C/fr not_active Expired - Fee Related
- 1998-06-15 CZ CZ0457799A patent/CZ299310B6/cs not_active IP Right Cessation
- 1998-06-15 EP EP98936363A patent/EP0999845B1/fr not_active Expired - Lifetime
- 1998-06-15 CN CNB988061880A patent/CN1168451C/zh not_active Expired - Fee Related
- 1998-06-15 UA UA99126878A patent/UA67743C2/uk unknown
- 1998-06-15 WO PCT/EP1998/003688 patent/WO1998057649A1/fr active IP Right Grant
- 1998-06-15 ES ES98936363T patent/ES2283064T3/es not_active Expired - Lifetime
- 1998-06-15 BR BR9810142-0A patent/BR9810142A/pt not_active Application Discontinuation
- 1998-06-15 NZ NZ501163A patent/NZ501163A/en unknown
- 1998-06-15 EA EA200000039A patent/EA003025B1/ru not_active IP Right Cessation
- 1998-06-15 KR KR1020087001560A patent/KR20080011356A/ko not_active Application Discontinuation
- 1998-06-17 MA MA25120A patent/MA24571A1/fr unknown
- 1998-06-17 AR ARP980102879A patent/AR008025A1/es not_active Application Discontinuation
- 1998-06-17 MY MYPI98002709A patent/MY125855A/en unknown
- 1998-06-17 AR ARP980102881A patent/AR012996A1/es unknown
- 1998-06-17 TW TW087109616A patent/TW542717B/zh not_active IP Right Cessation
- 1998-06-17 DZ DZ980132A patent/DZ2522A1/fr active
- 1998-06-18 CO CO98034645A patent/CO4940457A1/es unknown
- 1998-06-18 IN IN1692DE1998 patent/IN189319B/en unknown
- 1998-06-18 PE PE1998000532A patent/PE108199A1/es not_active Application Discontinuation
- 1998-06-18 UY UY25048A patent/UY25048A1/es not_active Application Discontinuation
-
1999
- 1999-12-17 OA OA9900293A patent/OA11510A/en unknown
- 1999-12-17 NO NO19996264A patent/NO326263B1/no not_active IP Right Cessation
-
2000
- 2000-01-06 BG BG104058A patent/BG64817B1/bg unknown
- 2000-01-06 BG BG109397A patent/BG109397A/bg unknown
- 2000-10-30 HK HK00106909A patent/HK1028200A1/xx not_active IP Right Cessation
-
2008
- 2008-07-24 NO NO20083276A patent/NO20083276L/no not_active Application Discontinuation
-
2009
- 2009-02-13 NO NO2009002C patent/NO2009002I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69834209D1 (de) | Bildverarbeitungsverfahren | |
TR199600357A2 (tr) | Rekombinant simanlik (Ob) proteinleri. | |
IL135440A0 (en) | Multithread data processor | |
EP1043991A4 (fr) | Traitement contre la maladie d'alzheimer | |
EP1021774A4 (fr) | Procede de traitement d'informations hyperliens | |
IL135584A0 (en) | Method for treating alzheimer's disease | |
MA24607A1 (fr) | Compositions comprenant un sensibilisant a l'insuline, un secretagogue d'insuline et un biguanide antihyperglycemique | |
MA24571A1 (fr) | Compositions comprenant un sensibilisant a l'insuline et un secretagogue d'insuline pour une methode de traitement | |
EP0984392A4 (fr) | Processeur d'image et procede correspondant | |
DZ2521A1 (fr) | Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement. | |
KR970703005A (ko) | 결상 재료의 결상 방법(improved imaging process for imaging materials) | |
EP0989753A4 (fr) | Processeur d'images et procede de traitement d'images | |
FR2766044B1 (fr) | Procede de traitement d'une sequence d'images radiologiques d'un objet | |
DE69813131T2 (de) | Bilderzeugungsverfahren | |
DE69524127T2 (de) | Flüssigentwicklerzusammensetzung | |
GB9406481D0 (en) | Border for an image | |
MA26510A1 (fr) | Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete | |
GB2324924B (en) | Image processing | |
AU123249S (en) | Developing processor for image formation | |
EP0921431A4 (fr) | Dispositif de developpement de photographies | |
GB9926284D0 (en) | Image processor and image processing method | |
GB2322993B (en) | Image processing | |
GB2289183B (en) | White level information correction apparatus | |
DE69812245D1 (de) | Elektrophotographisches Bildherstellungsverfahren | |
FR2772484B1 (fr) | Procede de traitement d'image d'autoradiographie |